The Leadership Team at Voyager Therapeutics is responsible for guiding the strategic direction of the company, ensuring compliance with regulatory requirements, and fostering innovation in gene therapy development. This team leverages their expertise in various fields, including regulatory affairs, neuroscience, vector engineering, and operational management, to oversee clinical advancements, drive research initiatives, and support the overall mission of delivering transformative treatments for severe neurological diseases.
Al Sandrock
CEO
Claire Sampson
VP Global Regulatory Affairs
Holger Patzke
Vice President, Neuroscience A...
Jay Hou
Vice President, Vector Enginee...
Jiachen Liu
Principal Computational Biolog...
Mark Kay
Scientific Founder & SAB membe...
Mathieu Nonnenmacher
Vice President, Capsid Discove...
Michelle Quinn Smith
Chief Human Resources Officer
Peter Pfreundschuh
CFO
Robin Swartz
COO
View all